To address the coronavirus disease 2019 (COVID-19) pandemic. several antiviral agents targeting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been developed for clinical use. However. antivirals that can be administered irrespective of risk factors were lacking until the approval of ensitrelvir fumaric acid (hereafter. https://stnicksknives.shop/product-category/flashlights/